• Online Features  This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (8)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Sigismund S. Pikul, II, MD; Norris J. Parks, PhD; Philip D. Schneider, MD, PhD

Arch Surg. 1987;122(12):1417-1420.

Abstract

• To better understand and optimize the mechanism of alpha particle killing of tumors, an in vitro model utilizing liposomes as carrier vehicles was developed to study the killing of melanoma via intracellular -irradiation. The radionuclide 212Pb (lead), with its 10.6-hour half-life and -emitting daughter 212Bi (bismuth), was encapsulated in liposomes to achieve the intracellular irradiation of melanoma cells in culture. In dose-response experiments, B16F10 mouse melanoma cells were incubated with liposomes²¹²Pb/²¹²Bi bound to dextran 70. Plating efficiency and growth of the melanoma cells cultured on gridded petri dishes after incubation were compared with controls at 24 and 48 hours. Greater than 85% cell killing occurred by 48 hours, with administered radioactivity levels of 1.6 dpm/µmol of lipid/cell, which corresponds to intracellular delivery of five to seven alpha particles per cell. These alpha doses can be exceeded in vivo with recirculation or in a perfusion circuit, and more efficient cytotoxic action may be possible.

(Arch Surg 1987;122:1417-1420)

Author Affiliations

Footnotes

Read before the Annual Meeting of the Society of Surgical Oncology, London, April 27, 1987.

Reprint requests to the Department of Surgery, University of Utah, 50 N Medical Dr, Salt Lake City, UT 84132 (Dr Schneider).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?